Sign in
Enrolling by invitationNo phase

Collects samples and brain scans from people with mood or psychotic disorders

Studies DNA, brain scans and clinical assessments in people with depression, bipolar or psychotic disorders.

Key facts

Who runs it
Vanderbilt University
Where
Nashville, United StatesSee the site
Trial code
Registry title
Psychiatric Genotype/Phenotype Project Repository
Status
Enrolling by invitation
People taking part
2,000 people, planned
Started
Sept 2008
Expected to end
Dec 2027
Type of study
Observational, 3 groups
Record updated
27 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 16 to 65 with major depression, bipolar disorder or a psychotic disorder, and for healthy volunteers with no history of mental illness.

Age
16 to 65 years
Sex
All sexes can join.
Disease stage
Unipolar major depressive disorder of any subtype, Bipolar I, Bipolar II or Bipolar Disorder NOS, or a psychotic disorder such as schizophrenia or schizoaffective disorder. Healthy controls with no history of any Axis I disorder can also join.

Main reasons for not taking part

  • Reported pregnancy or breastfeeding
  • Dementia or delirium
  • A medical condition that would interfere with taking part, such as uncontrolled diabetes, HIV infection, active hepatitis or a cancer involving the CNS
  • Healthy controls: any history of mental illness or psychotropic drug abuse
  • Conditions that interfere with MRI or PET scans, such as metal implants in the head (these people can still do the clinical assessment and give samples)

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Between the ages of 16 and 65
  • Able and willing to provide informed consent
  • Able to read and speak English sufficiently to provide consent and answer questions
  • Diagnosis of one of the following:; Unipolar Major Depressive Disorder of any subtype; Bipolar I, Bipolar II Disorder, or Bipolar Disorder NOS; Axis I Psychotic Disorder, which can include the diagnoses of Schizophrenia, Schizoaffective Disorder, Major Depression or Mania with Psychotic Features, Schizophreniform Disorder, Brief Psychotic Episode, or Psychotic Disorder NOS; Normal volunteer controls, individuals with no personal history of any Axis I disorder

Who cannot take part

  • Dementia or delirium
  • Any medical condition that would interfere with participation in the study. This would include, but not be limited to:; uncontrolled diabetes, hypothyroidism, Cushing's disease, or other significant endocrine condition (treated endocrine condition is allowed); demyelinating disease; HIV infection; active hepatitis; CNS infection; clinically significant and unstable cardiovascular disease; any cancer involving the CNS (including metastatic disease)
  • Exclusion criteria for normal control subjects include any history of mental illness or psychotropic drug abuse
  • Participants will be excluded from the imaging portion of the study if they have any condition deemed to interfere with PET or MRI scanning, such as but not restricted to extreme obesity, metal fragments in eyes, metal implants in the head, or cochlear implant. These participants may still take part in the portion of the study involving the clinical assessment and providing biological samples
  • Reported pregnancy or breastfeeding

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 65 years old?

Where in United States

  • Vanderbilt University Medical CenterNashville, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of this project is to obtain DNA, brain imaging data, other biological samples (e.g., urine, serum), and a comprehensive clinical assessment on patients with schizophrenia and other psychotic disorders, bipolar disorder, major depression, and normal volunteer controls. Understanding the physical and genetic factors related to these disorders will help us make progress in fitting treatments to an individual's needs. Participants will take part in a detailed clinical assessment, two blood draws, and an MRI scan over two visits. Participants will also be asked to provide urine and saliva samples.

The 3 groups in the trial

  • MDD

    Unipolar Major Depressive Disorder, any subtype

  • Bipolar

    Bipolar I or II Disorder or Bipolar Disorder NOS

  • Psychosis

    Psychotic Disorder including Schizophrenia, Schizoaffective, Schizophreniform, Brief Psychotic Disorder, and Psychotic Disorder NOS

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Psychiatric Genotype/Phenotype Project
Plain-language title
Collects samples and brain scans from people with mood or psychotic disordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT00762866, who can take part
Record updated
27 January 2026